Chemoinformaics analysis of 1,1,3-Trimethylcyclohexane
| Molecular Weight | 126.243 | nRot | 0 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 6 |
| Exact Molecular Weight | 126.141 | nRing | 1 |
| Solubility: LogS | -4.561 | nHRing | 0 |
| Solubility: LogP | 4.463 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0323 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.467 |
| Synth | 2.623 |
| Natural Product Likeliness | 1.451 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.377 |
| MDCK | 0.0000148 |
| BBB | 0.901 |
| PPB | 0.897901 |
| VDSS | 2.182 |
| FU | 0.154312 |
| CYP1A2-inh | 0.673 |
| CYP1A2-sub | 0.864 |
| CYP2c19-inh | 0.512 |
| CYP2c19-sub | 0.9 |
| CYP2c9-inh | 0.271 |
| CYP2c9-sub | 0.906 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.633 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.176 |
| CL | 7.455 |
| T12 | 0.204 |
| hERG | 0.026 |
| Ames | 0.012 |
| ROA | 0.039 |
| SkinSen | 0.73 |
| Carcinogencity | 0.132 |
| EI | 0.983 |
| Respiratory | 0.743 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.943591 |